Dnmt1 methylates CpG residues preferentially on hemimethylated DNA for maintaining methylation patterns established during development.The synthetic peptide used to raise the antibody Cat. No. 200101 is selected from a sequence within the N-term region of human Dnmt1. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.